These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30574406)

  • 1. Limitations to the use of bromelain-based enzymatic debridement (NexoBrid
    Berner JE; Keckes D; Pywell M; Dheansa B
    Scars Burn Heal; 2018; 4():2059513118816534. PubMed ID: 30574406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eschar removal by bromelain based enzymatic debridement (Nexobrid
    Hirche C; Citterio A; Hoeksema H; Koller J; Lehner M; Martinez JR; Monstrey S; Murray A; Plock JA; Sander F; Schulz A; Ziegler B; Kneser U
    Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R
    Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries.
    Hasham S; Riyat H; Fletcher A; O'Boyle CP; Alexander S
    Scars Burn Heal; 2023; 9():20595131231168333. PubMed ID: 37124159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes.
    Shoham Y; Gasteratos K; Singer AJ; Krieger Y; Silberstein E; Goverman J
    Int Wound J; 2023 Dec; 20(10):4364-4383. PubMed ID: 37455553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Single-Center Experience of Bromelain-Based Eschar Removal in Children with Mixed Deep Dermal and Full Thickness Burns.
    Korzeniowski T; Grywalska E; Strużyna J; Bugaj-Tobiasz M; Surowiecka A; Korona-Głowniak I; Staśkiewicz M; Torres K
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence.
    Loo YL; Goh BKL; Jeffery S
    J Burn Care Res; 2018 Oct; 39(6):932-938. PubMed ID: 29579268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic debridement for circumferential deep burns: the role of surgical escharotomy.
    Grünherz L; Michienzi R; Schaller C; Rittirsch D; Uyulmaz S; Kim BS; Giovanoli P; Lindenblatt N
    Burns; 2023 Mar; 49(2):304-309. PubMed ID: 36604280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Bromelain Activity During Enzymatic Debridement of Burn Wounds Pretreated With Frequently Used Products.
    Schulz A; Fuchs PC; Hans N; Opländer C; Valdez LB; Schiefer JL
    J Burn Care Res; 2018 Apr; 39(3):413-422. PubMed ID: 29897542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic debridement: past, present, and future.
    De Decker I; De Graeve L; Hoeksema H; Monstrey S; Verbelen J; De Coninck P; Vanlerberghe E; Claes KEY
    Acta Chir Belg; 2022 Aug; 122(4):279-295. PubMed ID: 35440290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
    Ho W; Jones CD; Widdowson D; Bahia H
    J Wound Care; 2019 Nov; 28(11):758-761. PubMed ID: 31721672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cadaver model as a training tool for enzymatic burn debridement (Nexobrid®): A feasibility study.
    Wen J; Johnson K; O'Boyle CP
    Burns; 2022 Nov; 48(7):1706-1709. PubMed ID: 35210140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®.
    Sharaf A; Muthayya P
    Burns; 2022 Nov; 48(7):1618-1625. PubMed ID: 34973852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
    Korzeniowski T; Strużyna J; Chrapusta AM; Krajewski A; Kucharzewski M; Piorun K; Nowakowski J; Surowiecka A; Kozicka M; Torres K
    Med Sci Monit; 2022 Jan; 28():e935632. PubMed ID: 35064095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helpful hints in deciding what and when to operate after enzymatic debridement.
    Claes KEY; De Decker I; Monstrey S; Shoham Y; Vyncke T; Depypere B; De Wolf E; Decuypere F; Lannau B; Hoeksema H
    Burns; 2023 Feb; 49(1):80-90. PubMed ID: 35177282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic Debridement With Nexobrid
    Claes KEY; De Decker I; Vyncke T; Verbelen J; Dhooghe N; Monstrey S; Hoeksema H
    Ann Burns Fire Disasters; 2023 Dec; 36(4):347-354. PubMed ID: 38680243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic Debridement of Deep Thermal Burns in the Russian Federation: First Experience.
    Alekseev AA; Malyutina NB; Bobrovnikov AE; Shoham Y
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U
    Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing Nexobrid for Burn Debridement in a Major Italian Burn Center: A Retrospective Review of Patient Outcomes.
    Lombardo GAG; Ciancio F; Violini H; Sapuppo C; Zagami S; Vena A; Giardina M; Donia C; Ranno R
    J Burn Care Res; 2024 Mar; 45(2):432-437. PubMed ID: 37897805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Enzymatic Burn Debridement: Results of the DETECT Multicenter Randomized Controlled Trial.
    Shoham Y; Rosenberg L; Hickerson W; Goverman J; Iyer N; Barrera-Oro J; Lipovy B; Monstrey S; Blome-Eberwein S; Wibbenmeyer LA; Scharpenberg M; Singer AJ
    J Burn Care Res; 2024 Mar; 45(2):297-307. PubMed ID: 37715999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.